STAT3 in Prostate Cancer: Whom Should We Treat and When?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference10 articles.
1. EC-70124, a novel glycosylated indolocarbazole multikinase inhibitor, reverts tumorigenic and stem cell properties in prostate cancer by inhibiting STAT3 and NF-κB;Civenni;Mol Cancer Ther,2016
2. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells;Moreira;Oncotarget,2015
3. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation;Wang;Int J Cancer,2004
4. STAT3 regulated ARF expression suppresses prostate cancer metastasis;Pencik;Nat Commun,2015
5. Expression of STAT3 in prostate cancer metastases;Don-Doncow;Eur Urol,2017
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of IL-22 in cancer;Medical Oncology;2024-09-05
2. Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy;Marine Life Science & Technology;2023-02-06
3. HSPB8 facilitates prostate cancer progression via activating the JAK/STAT3 signaling pathway;Biochemistry and Cell Biology;2023-02-01
4. Synthesis of KUE‐siRNA Conjugates for Prostate Cancer Cell‐Targeted Gene Silencing;ChemBioChem;2021-07-30
5. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling;Biomedicine & Pharmacotherapy;2019-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3